Mounjaro (Tirzepatide) Clinical Access & Endocrinology Guide: Delhi NCR

Premier medical institutions, extreme summer cold-chain management, and physician evaluation pathways across Delhi, Gurugram, and Noida.

1. Medical Evaluation & Dual Incretin Action

Tirzepatide is a dual agonist targeting both GIP and GLP-1 receptors. It acts centrally on appetite centers in the hypothalamus and peripherally to delay gastric emptying and enhance insulin sensitivity.

2. Tertiary Healthcare & Endocrinology Hubs in Delhi NCR

Patients in Delhi, Gurugram, Noida, and Faridabad can consult metabolic and endocrinology specialists across established academic and tertiary hospitals:

  • All India Institute of Medical Sciences (AIIMS, New Delhi) - Department of Endocrinology & Metabolism
  • Medanta - The Medicity (Gurugram) - Division of Endocrinology & Diabetes
  • Max Super Speciality Hospital (Saket) - Institute of Endocrinology, Diabetes & Metabolism
  • Fortis Memorial Research Institute (FMRI, Gurugram) - Endocrine Care Division

3. High-Temperature Cold Chain Management

Delhi NCR's extreme summer ambient temperatures exceeding 40°C require strict insulated cold-chain transport with calibrated gel packs to prevent thermal peptide degradation during courier transit.

Never leave medicine pens inside a parked car or near windows during Delhi summers. Unused pens must remain continuously in domestic refrigeration at 2°C–8°C.